
AFFILIATES, SKILLS & QUALIFICATIONS
​
Australia is a significant global location for drug development and has a reputation for delivering premium data and being a reliable contributor to global clinical trials.
​
Australia has a rigorous ethical and regulatory clinical trial's system in place and a cohort of experienced and talented clinical research professionals who understand the work of global clinical teams and can deliver superior results to tight deadlines.
The professional expertise at Veracity Clinical Research enables early phase, complex clinical trials to be undertaken and translational medicine expertise to be leveraged adding value to global drug development programs. Veracity conducts studies at all phases, across all ages and all culturally diverse populations.
 
Our Principal Investigator, Dr Lynda Spelman, has been involved enthusiastically in dermatology research pursuits for over 30 years.
Veracity Clinical Research's infrastructure supports speedy trial establishment and timely delivery. The single ethical review process, expert ethics review committees and standard collaborator contracts, work together to make setting up, commencing and conducting a trial straightforward, efficient and effective. Veracity has an excellent patient participant pool and strives to exceed recruitment targets for all its trials.
 
The team at Veracity Clinical Research are trained in GCP guidelines, PASI and SCORAD assessments and are regularly upskilled in clinical assessment criteria. The Veracity team routinely carry out ECGs through Quintiles and ERT; pathology collection including international shipping of specimens (IATA); electronic record management, use and are familiar with most IVRS and IWX systems; ECRF's including iMedidata, Inform and Oracle RDC and Canfield photography.
 
Veracity Clinical Research trials are recognised internationally, with collaborating companies in Canada, United States of America, Japan and Europe.  Veracity liaises with local and international pathology laboratories, radiology practices and histopathology and other affiliated organisations to maximise efficiency and meet the requirements of multi-disciplinary trials.
